<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H585F41D4260242159FFF3773B48C550A" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 3528 IH: Every Prescription Conveyed Securely Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2017-07-28</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 3528</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20170728">July 28, 2017</action-date><action-desc><sponsor name-id="C001101">Ms. Clark of Massachusetts</sponsor> (for herself and <cosponsor name-id="M001190">Mr. Mullin</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend title XVIII of the Social Security Act to require e-prescribing for coverage under part D
			 of the Medicare program of prescription drugs that are controlled
			 substances.</official-title></form>
	<legis-body id="H5C8FE82343054F929EA748A15765EC07" style="OLC">
 <section id="H907AF5C72BD5456996E6E32B41BF8E06" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Every Prescription Conveyed Securely Act</short-title></quote>.</text> </section><section id="H510CEEE09566494E960ED25E1A221B11"><enum>2.</enum><header>Requiring e-prescribing for coverage of covered part D controlled substances</header> <subsection id="HB37C7E67778843B6AF7CA5532B3884EE"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1860D–4(e) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-104">42 U.S.C. 1395w–104(e)</external-xref>) is amended by adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="HD3DBF02CF4D9443B940F24688B069551" style="OLC">
					<paragraph id="H85CACB84F7D947D0BFB63E873920BE59"><enum>(7)</enum><header>Requirement of e-prescribing for controlled substances</header>
 <subparagraph id="H38569435E30943E29F193808B52505C7"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">Subject to subparagraph (B), a prescription for a covered part D drug under a prescription drug plan (or under an MA–PD plan) for a schedule II, III, IV, or V controlled substance shall be transmitted by a health care practitioner electronically in accordance with an electronic prescription drug program that meets the requirements of paragraph (2).</text>
 </subparagraph><subparagraph id="H0678534E43504C609426C4108633C1A2"><enum>(B)</enum><header>Exception for certain circumstances</header><text display-inline="yes-display-inline">The Secretary shall, pursuant to rulemaking, specify circumstances with respect to which the Secretary may waive the requirement under subparagraph (A), with respect to a covered part D drug, including in the case of—</text>
 <clause id="HAE1AA34270C44ACAA7B5F479B9671422"><enum>(i)</enum><text display-inline="yes-display-inline">a prescription issued when the prescriber and dispenser are the same entity;</text> </clause><clause id="HAF2236104BE14FEA8AFFC083F65FD08F"><enum>(ii)</enum><text>a prescription issued that cannot be transmitted electronically due to the constraints of the most recently implemented version of the National Council for Prescription Drug Programs SCRIPT Standard;</text>
 </clause><clause id="H3A9A7294F4984AFAA73DF1FDD6DBF131"><enum>(iii)</enum><text>a prescription issued by a practitioner who has received a waiver or a renewal thereof for a specified period determined by the Secretary, not to exceed one year, from the requirement to use electronic prescribing, pursuant to a process established by regulation by the Secretary, due to demonstrated economic hardship, technological limitations that are not reasonably within the control of the practitioner, or other exceptional circumstance demonstrated by the practitioner;</text>
 </clause><clause id="H10B88C0F60D84316A9294D346473FD41"><enum>(iv)</enum><text>a prescription issued by a practitioner under circumstances in which, notwithstanding the practitioner’s ability to make an electronic prescription as required by this subsection, such practitioner reasonably determines that it would be impractical for the individual involved to obtain substances prescribed by electronic prescription in a timely manner, and such delay would adversely impact the individual’s medical condition involved;</text>
 </clause><clause id="HB841A510A5A44F2085401682715944F8"><enum>(v)</enum><text display-inline="yes-display-inline">a prescription issued by a practitioner allowing for the dispensing of a non-patient specific prescription pursuant to a standing order, approved protocol for drug therapy, collaborative drug management, or comprehensive medication management, in response to a public health emergency, or other circumstances where the practitioner may issue a non-patient specific prescription;</text>
 </clause><clause id="HB1479979658A4357839951A58709C61A"><enum>(vi)</enum><text>a prescription issued by a practitioner prescribing a drug under a research protocol; and</text> </clause><clause id="H7D77A1AE3ED9459AAA0834725DD1C9DB"><enum>(vii)</enum><text display-inline="yes-display-inline">a prescription issued by a practitioner for a drug for which the Food and Drug Administration requires the prescription to contain certain elements that are not able to be accomplished with electronic prescribing such as, a drug with risk evaluation and mitigation strategies that include elements to assure safe use.</text>
 </clause></subparagraph><subparagraph id="HB22F5C732CEA4CC29D1D61B76556CC19"><enum>(C)</enum><header>Dispensing</header><text display-inline="yes-display-inline">Nothing in this paragraph shall be construed as requiring a sponsor of a prescription drug plan under this part, MA organization offering an MA–PD plan under part C, or a pharmacist to verify that a practitioner, with respect to a prescription for a covered part D drug, has a waiver (or is otherwise exempt) under subparagraph (B) from the requirement under subparagraph (A). Nothing in this paragraph shall be construed as affecting the ability of the plan to cover or the pharmacists’ ability to continue to dispense covered part D drugs from otherwise valid written, oral or fax prescriptions that are consistent with laws and regulations.</text>
 </subparagraph><subparagraph id="H1D7B9DBB0AC142208B6E00D0DAC8F05E"><enum>(D)</enum><header>Enforcement</header><text display-inline="yes-display-inline">The Secretary shall, pursuant to rulemaking, have authority to enforce and specify appropriate penalties for non-compliance with the requirement under subparagraph (A).</text></subparagraph></paragraph><after-quoted-block>. </after-quoted-block></quoted-block>
 </subsection><subsection id="HA664FF55FEC244E3AFA440E6779C7FAD"><enum>(b)</enum><header>Effective date</header><text>The amendment made by subsection (a) shall apply to coverage of drugs prescribed on or after January 1, 2020.</text>
			</subsection></section></legis-body></bill>


